U.S. Stock News

NasdaqGS:NBIX
NasdaqGS:NBIXBiotechs

Neurocrine’s Two Year CAH Data May Reframe NBIX Valuation Story

Neurocrine Biosciences (NasdaqGS:NBIX) reported new two‑year Phase 3 data from its CAHtalyst Pediatric and Adult trials of CRENESSITY in classic congenital adrenal hyperplasia. The peer‑reviewed results cover both children and adults and highlight durable efficacy alongside physiologic glucocorticoid dosing. Data show sustained reductions in harmful steroid exposure and clinical improvements, including better body mass index and insulin resistance in pediatric patients. These findings...
NYSE:CRC
NYSE:CRCOil and Gas

Does Vanguard’s 5.94% Stake Reframe CRC’s Carbon Strategy Amid Softer Earnings Expectations?

In the lead-up to its 5 May 2026 earnings release, California Resources Corporation has been projected to post year-over-year declines in earnings and modestly lower revenues, even as Vanguard Portfolio Management disclosed a passive 5.94% ownership stake as of 31 March 2026. This combination of cautious profit expectations and increased institutional ownership highlights how investors are repositioning around California Resources’ evolving earnings profile and carbon-focused business...
NasdaqGS:BNTX
NasdaqGS:BNTXBiotechs

BioNTech Faces Tariff Risks And Leadership Shift As Oncology Plans Advance

BioNTech, NasdaqGS:BNTX, faces potential U.S. pharmaceutical tariffs that could affect access to a key market. The company is preparing for the announced departures of its co founders from leadership roles. These developments arrive while the share price stands at $97.54 and recent returns show mixed performance across different time frames. For investors watching NasdaqGS:BNTX, these leadership changes and tariff risks are landing on a share price of $97.54, with recent moves including a...
NasdaqGS:SMTC
NasdaqGS:SMTCSemiconductor

A Look At Semtech’s Valuation As Analysts Expect Another Earnings Beat

Semtech (SMTC) is back in focus after analysts highlighted its recent track record of exceeding earnings estimates and a current positive Earnings ESP, with supportive ratings indicating firm expectations for its upcoming results. See our latest analysis for Semtech. At a share price of $107.81, Semtech has seen a 30 day share price return of 34.7% and a year to date share price return of 43.25%. Its 1 year total shareholder return of 215.88% and 3 year total shareholder return of close to 5x...
NasdaqGS:CCC
NasdaqGS:CCCSoftware

CCC Mobile Scanning Links AI Automation With CCC ONE Usage And Valuation

CCC Intelligent Solutions Holdings launched mobile invoice scanning in the CCC ONE platform, integrating directly into its repair management workflow. The new feature uses AI to match invoice line items to repair orders, automating parts reconciliation for repair shops. The capability is available at no additional cost to users of CCC ONE, aiming to cut manual data entry and reduce processing time. CCC Intelligent Solutions Holdings, traded as NasdaqGS:CCC, is rolling out this product...
NasdaqGS:ARLP
NasdaqGS:ARLPOil and Gas

Can Alliance Resource Partners (ARLP) Sustain Distributions After a Sharp Earnings Drop and Steady Volume Guidance?

Alliance Resource Partners, L.P. recently reported first-quarter 2026 results showing revenue of US$516.02 million and net income of US$9.09 million, both lower than the same period a year earlier, while also affirming a quarterly cash distribution of US$0.60 per unit payable in May. Despite the sharp earnings drop, the partnership maintained its distribution and issued full-year 2026 coal sales volume guidance of 33.75 million to 35.25 million short tons, highlighting management’s focus on...
NasdaqGS:LSCC
NasdaqGS:LSCCSemiconductor

Assessing Lattice Semiconductor (LSCC) Valuation After New Texas Instruments Edge AI Partnership

Texas Instruments collaboration puts Lattice’s edge AI focus in the spotlight Lattice Semiconductor (LSCC) has drawn fresh attention after announcing a collaboration with Texas Instruments that links Lattice’s low power FPGA based Holoscan Sensor Bridge with TI sensing technologies for real time edge AI systems. See our latest analysis for Lattice Semiconductor. The Texas Instruments partnership arrives after a strong run in the stock, with a 30 day share price return of 27.3% and a 90 day...
NYSE:TDC
NYSE:TDCSoftware

Is It Time To Reconsider Teradata (TDC) After Recent Share Price Recovery?

If you are wondering whether Teradata is attractively priced or looking stretched at its current levels, you will want to understand what the valuation numbers are actually saying. The stock last closed at US$27.96, with returns of 5.8% over the past week, 10.8% over the past month, a 5.8% decline year to date, and 26.7% over the last year, alongside weaker 3 year and 5 year returns of 37.2% and 31.0% respectively. These mixed returns have kept Teradata on the radar for investors who pay...
NYSEAM:PRK
NYSEAM:PRKBanks

Rising Net Interest Income and Charge‑Offs Might Change The Case For Investing In Park National (PRK)

In April 2026, Park National Corporation reported first-quarter 2026 results showing higher net interest income of US$125.78 million but slightly lower net income of US$41.69 million and earnings per share, alongside a quarterly dividend declaration of US$1.10 per share. The quarter also featured a rise in net charge-offs to US$2.63 million from US$592,000 a year earlier, putting asset quality trends in sharper focus for investors. We’ll now look at how the mix of rising net interest income...
NYSE:ADC
NYSE:ADCRetail REITs

Did ADC’s US$1 Billion Equity Raise and New Shelf Just Redefine Agree Realty’s Funding Playbook?

In April 2026, Agree Realty Corporation completed roughly US$1.00 billion of follow-on common equity offerings and filed an additional US$1.75 billion at-the-market equity program alongside a new universal shelf registration covering common and preferred stock, depositary shares, warrants, and debt securities. This combination of fresh equity capital and expanded shelf capacity signals that Agree Realty is preparing for a potentially larger, more flexible funding toolkit to support its...
NYSE:BLSH
NYSE:BLSHCapital Markets

Assessing Bullish (BLSH) Valuation After Strong Recent Momentum And A Rich P/S Multiple

Bullish (BLSH) has drawn attention after its recent trading performance, with a 4.2% move over the past day, a small decline over the past week, and double digit gains over the past month and past 3 months. See our latest analysis for Bullish. That recent 4.21% 1 day share price return comes after a 12.12% 30 day and 30.20% 90 day share price return. This suggests momentum has been building even though the year to date share price return is close to flat. If Bullish has you looking more...
NYSE:GRMN
NYSE:GRMNConsumer Durables

Garmin’s Record Q1 And EU Wins Raise Questions On Growth Mix

Garmin (NYSE:GRMN) reports record Q1 2026 revenue and operating income, setting new highs for the company. Fitness segment revenue rises 42% in Q1 2026, supported by advanced wearables and recent product launches. Garmin plans around 100 product launches in 2026 across its diversified segments. The company secures multiple new EASA certifications for aviation equipment, expanding its presence in the European market. For investors tracking consumer electronics and aerospace, Garmin sits at...
NYSE:BLX
NYSE:BLXDiversified Financial

Bladex Rebrand Puts NYSE BLX Valuation And Dividend Record In Focus

Banco Latinoamericano de Comercio Exterior S. A. gained shareholder approval at its recent Annual Shareholders' Meeting to change its legal name to Bladex Inc. The rebranding will shift the company’s official identity while it continues to trade on the NYSE under ticker NYSE:BLX. The name change is expected to influence how the bank presents itself to clients, investors, and counterparties across Latin America and beyond. The rebrand to Bladex Inc. comes at a time when NYSE:BLX shares are...
NasdaqGS:NVCR
NasdaqGS:NVCRMedical Equipment

NovoCure’s Optune Pax Win And TRIDENT Data Shape Growth Outlook

NovoCure (NasdaqGS:NVCR) received FDA approval for Optune Pax for locally advanced pancreatic cancer and has started its U.S. commercial launch. The new therapy has seen early adoption and payer coverage in the U.S., expanding NovoCure's reach beyond its original focus in glioblastoma. Pivotal Phase 3 data from the TRIDENT trial in newly diagnosed glioblastoma are expected later this year. NovoCure focuses on tumor treating fields therapy, a medical technology designed to disrupt cancer...
NasdaqGM:OCUL
NasdaqGM:OCULPharmaceuticals

What Ocular Therapeutix (OCUL)'s SOL-X Long-Term AXPAXLI Extension Study Means For Shareholders

Ocular Therapeutix recently enrolled the first patient in its SOL-X long-term extension trial of AXPAXLI (OTX-TKI) for wet age-related macular degeneration, a 36‑month open-label study designed to assess long-term safety, efficacy, and disease-modifying potential following completion of the SOL-1 or SOL-R trials. This extension study is intended to test whether earlier and sustained AXPAXLI therapy can reduce fibrosis, macular atrophy, and treatment burden compared with pulsatile anti-VEGF...
NYSE:MTZ
NYSE:MTZConstruction

MasTec (MTZ) Q1 Earnings Show 2.9% Net Margin That Tests Bullish Expansion Narrative

MasTec (MTZ) opened Q1 2026 with revenue of about US$3.8b and basic EPS of US$0.78, setting the tone for how the rest of the year may shape up on both the top and bottom line. Over the past six reported quarters, revenue has moved from US$3.4b in Q4 2024 to just under US$4.0b in Q3 2025 before landing at US$3.8b in the latest quarter. Quarterly basic EPS has ranged from US$0.13 in Q1 2025 to US$2.07 in Q3 2025 and stands at US$0.78 in Q1 2026. With trailing twelve month net income of...
NYSE:AR
NYSE:AROil and Gas

Record Output And HG Synergies Could Be A Game Changer For Antero Resources (AR)

Antero Resources reported past first-quarter 2026 results with revenue of US$1,945.13 million, net income of US$535.22 million, and record production of 3,852 MMcfe/d, alongside sharply lower property and equipment impairment charges. The company also reaffirmed its 2026 production guidance while highlighting ahead-of-schedule integration of the HG acquisition, which is already contributing to higher volumes and operational efficiencies. We’ll now examine how this record quarterly...
NYSE:RBRK
NYSE:RBRKSoftware

Does Rubrik (RBRK) Offer Value After Recent Share Price Rebound?

If you are wondering whether Rubrik's current share price reflects its true worth, this breakdown will help you connect the recent moves in the stock to what the underlying valuation signals are saying. Rubrik last closed at US$55.07, with returns of 5.3% over the past week and 13.3% over the past month, while the 1 year return sits at a 24.9% decline. Recent trading interest has been influenced by ongoing attention on data security and cloud software providers, as investors reassess how...
NYSE:AWK
NYSE:AWKWater Utilities

American Water Works Merger News Tests Valuation And Recent Share Weakness

American Water Works Company (NYSE:AWK) has announced a proposed merger with Essential Utilities to create a large regulated U.S. water and wastewater utility. The combined business would bring together regulated water and wastewater operations across multiple states, subject to regulatory and shareholder approvals. The companies plan to integrate networks and services to serve a wider customer base under a unified regulated utility structure. For investors watching NYSE:AWK, this update...
NYSE:FCF
NYSE:FCFBanks

First Commonwealth Deposit Growth And Center Bank Synergy Underpin Valuation Gap

First Commonwealth Financial (NYSE:FCF) reports strong deposit growth across its banking franchise. The company completes and reports successful integration of its Center Bank acquisition. Management highlights solid mortgage activity and steady demand from small business banking clients. For investors tracking NYSE:FCF, this update adds fresh detail beyond headline financials. The stock closed at $18.46, with a 10.1% gain year to date and a 20.0% return over the past year, while the 3-year...
NasdaqGS:IQ
NasdaqGS:IQEntertainment

What iQIYI (IQ)'s Nadou Pro AI Push Means For Shareholders

In April 2026, iQIYI unveiled its Nadou Pro AI production platform and broader AI-driven creator ecosystem in Beijing, while also showcasing AI-powered storytelling and Chinese anime through an immersive AI Theater collaboration with Blacklyte at the LVL UP EXPO in Las Vegas. Together, these initiatives highlight iQIYI’s push to industrialize AI-assisted content creation, lower creator barriers, and extend its premium IP to international audiences. We’ll now examine how Nadou Pro’s...
NYSE:EPD
NYSE:EPDOil and Gas

Is It Too Late To Consider Enterprise Products Partners (EPD) After Its Strong Multi‑Year Rally?

If you are asking whether Enterprise Products Partners is still reasonably priced after a long run in the unit price, this article walks through what the current valuation really reflects and where the key pressure points are. The units last closed at US$38.03, with stated returns of 0.1% over 7 days, 1.6% over 30 days, 18.3% year to date, 33.3% over 1 year, 83.1% over 3 years and 134.3% over 5 years, which gives plenty of context for a closer look at value. Recent coverage has focused on...
NYSE:THC
NYSE:THCHealthcare

Is It Time To Reassess Tenet Healthcare (THC) After Its Strong Three Year Share Price Run?

If you are wondering whether Tenet Healthcare at a recent close of US$183.27 still offers value or is looking stretched, the numbers behind the share price can help frame that decision. The stock has returned 1.4% over the last 7 days, while the 30 day and year to date returns of 3.7% decline and 8.1% decline sit alongside a 23.8% return over the last year and 164.3% over 3 years. Recent coverage has focused on Tenet Healthcare's position in the US hospital and healthcare services space,...
NYSE:TSN
NYSE:TSNFood

Is Tyson Foods (TSN) Pricing Look Attractive After Recent Share Price Softness?

If you are wondering whether Tyson Foods at around US$63.68 is a bargain or a value trap, the key is to look past the headline share price and into what the current valuation actually reflects. The stock has slipped about 0.5% over the last week and 1.0% over the last month, but is still showing a 9.7% return year to date and 8.5% over the last year, which can change how investors think about both opportunity and risk. Recent coverage has focused on Tyson Foods as a major player in U.S...